ロード中...
Cariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy
Cariprazine is an oral antipsychotic approved in the US and EU for the treatment of schizophrenia. Cariprazine differs from other antipsychotics in that it is a dopamine D(3)- and D(2)-receptor partial agonist, with tenfold higher affinity for D(3) receptors than for D(2) receptors. Cariprazine is m...
保存先:
| 出版年: | Neuropsychiatr Dis Treat |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6179724/ https://ncbi.nlm.nih.gov/pubmed/30323605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S159704 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|